Most cited papers from Ospedale San Bortolo

Ospedale San Bortolo

What are the most cited papers from Ospedale San Bortolo?

The most cited paper from Ospedale San Bortolo is "Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury" (Ravindra L. Mehta, John A. Kellum, Sudhir V. Shah et al., 2007), with 7,137 citations. Next come "Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group" (6,870) and "Understanding Bland Altman analysis" (4,112).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 400 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury Ravindra L. Mehta, John A. Kellum, Sudhir V. Shah et al. · Critical Care Open access	Mar 2007	7,137
2	Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group Rinaldo Bellomo, Claudio Ronco, John A. Kellum et al. · Critical Care Open access	22 May 2004	6,870
3	Understanding Bland Altman analysis Davide Giavarina · Biochemia Medica Open access	2015	4,112
4	Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer et al. · Blood Open access	12 Nov 2008	2,707
5	Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 Christina Fitzmaurice et al. · JAMA Oncology Open access628 authors	27 Sep 2019	2,699
6	Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology	10 Dec 2011	2,403
7	International consensus report on the investigation and management of primary immune thrombocytopenia Drew Provan et al. · Blood Open access	21 Oct 2009	2,283
8	Acute kidney injury Claudio Ronco, Rinaldo Bellomo, John A. Kellum · The Lancet	Nov 2019	1,907
9	Cardiorenal Syndrome Claudio Ronco, Mikko Haapio, Andrew A. House et al. · Journal of the American College of Cardiology Open access	29 Oct 2008	1,883
10	Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma Noel Weidner, Judah Folkman, Franco Dalla Pozza et al. · JNCI Journal of the National Cancer Institute	16 Dec 1992	1,800
11	Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial Claudio Ronco, Rinaldo Bellomo, Peter Homel et al. · The Lancet	Jul 2000	1,598
12	Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor J. Evan Sadler et al. · Journal of Thrombosis and Haemostasis Open access	14 Sep 2006	1,154
13	Updated international consensus report on the investigation and management of primary immune thrombocytopenia Drew Provan et al. · Blood Advances Open access	26 Nov 2019	1,151
14	Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative Claudio Ronco et al. · European Heart Journal Open access	25 Dec 2009	1,099
15	ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach Claudio Luchini, Frédéric Bibeau, M.J.L. Ligtenberg et al. · Annals of Oncology ReviewOpen access	29 Mar 2019	1,083
16	Epidemiological investigation of the prevalence of von Willebrand's disease F Rodeghiero, Giancarlo Castaman, E Dini · Blood Open access	Feb 1987	1,006
17	An assessment of the RIFLE criteria for acute renal failure in hospitalized patients* Shigehiko Uchino, Rinaldo Bellomo, Donna Goldsmith et al. · Critical Care Medicine	18 May 2006	944
18	ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders Francesco Rodeghiero, Alberto Tosetto, Thomas C. Abshire et al. · Journal of Thrombosis and Haemostasis Open access	6 Jul 2010	887
19	Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis Sergio Cortelazzo, Guido Finazzi, Marco Ruggeri et al. · New England Journal of Medicine Open access	27 Apr 1995	856
20	Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock Dinna N. Cruz, Massimo M. Antonelli, Roberto Fumagalli et al. · JAMA	16 Jun 2009	849
21	Cardiovascular Events and Intensity of Treatment in Polycythemia Vera Roberto Marchioli et al. · New England Journal of Medicine Open access	8 Dec 2012	845
22	Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome Vittorio Pengo et al. · Blood Open access	12 Jul 2018	821
23	The RIFLE criteria and mortality in acute kidney injury: A systematic review Zaccaria Ricci, D. Cruz, Claudio Ronco · Kidney International ReviewOpen access	26 Dec 2007	804
24	Acute kidney injury in sepsis Rinaldo Bellomo, John A. Kellum, Claudio Ronco et al. · Intensive Care Medicine Open access	31 Mar 2017	791
25	Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup Alexander Zarbock et al. · Nature Reviews Nephrology ReviewOpen access	23 Feb 2023	772
26	Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation Peter B. Vermeulen, Giampietro Gasparini, Stephen B. Fox et al. · European Journal of Cancer	Dec 1996	740
27	Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study Ayalew Tefferi et al. · Leukemia Open access	6 Jun 2013	704
28	MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program Shimin Hu et al. · Blood Open access	Mar 2013	686
29	Management of acute kidney injury in patients with COVID-19 Claudio Ronco, Thiago de Azevedo Reis, Faeq Husain‐Syed · The Lancet Respiratory Medicine Open access	15 May 2020	671
30	High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial Andrés JM Ferreri et al. · The Lancet Open access	19 Sep 2009	668
31	d -Dimer Testing to Determine the Duration of Anticoagulation Therapy Gualtiero Palareti, Benilde Cosmi, Cristina Legnani et al. · New England Journal of Medicine	25 Oct 2006	629
32	Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis) Tiziano Barbui, Guido Finazzi, Alessandra Carobbio et al. · Blood Open access	2 Oct 2012	606
33	Continuous renal replacement therapy: A worldwide practice survey Shigehiko Uchino, Rinaldo Bellomo, Hiroshi Morimatsu et al. · Intensive Care Medicine	26 Jun 2007	578
34	Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data Gioacchino Leandro, Alessandra Mangia, Jason Minco Hui et al. · Gastroenterology Review	May 2006	562
35	Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study Francesco Passamonti et al. · The Lancet Haematology Open access	13 Aug 2020	555
36	MAIT cells are activated during human viral infections Bonnie van Wilgenburg et al. · Nature Communications Open access	23 Jun 2016	532
37	A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD) Alberto Tosetto et al. · Journal of Thrombosis and Haemostasis Open access	15 Mar 2006	529
38	Fluid balance and acute kidney injury John Richard Prowle, Jorge Enrique Echeverri, E. Valentina Ligabo et al. · Nature Reviews Nephrology Review	22 Dec 2009	517
39	Impact, Diagnosis and Treatment of von Willebrand Disease J. Evan Sadler, Erik E. Berntorp, Н. П. Бочков et al. · Thrombosis and Haemostasis	2000	505
40	Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast Carcinoma Giulio Maria Gasparini, Emanuela Bonoldi, Carlo Gatti et al. · JNCI Journal of the National Cancer Institute	15 Jan 1997	497
41	Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study Emmanuel Ekanem et al. · Nature Medicine Open access139 authors	Jul 2024	484
42	A pilot study of coupled plasma filtration with adsorption in septic shock* Claudio Ronco, Alessandra Brendolan, Gerhard Lonnemann et al. · Critical Care Medicine	Jun 2002	483
43	Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions Zoran Olivari, Paolo Rubartelli, Federico Piscione et al. · Journal of the American College of Cardiology Open access	May 2003	482
44	Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. Giampietro Gasparini, Noel Weidner, Pierantonio Bevilacqua et al. · Journal of Clinical Oncology	Mar 1994	469
45	Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials Christopher Ryan King, Debra E. Freeman, Irving Kaplan et al. · Radiotherapy and Oncology Open access	20 Sep 2013	464
46	Acute renal failure: time for consensus Rinaldo Bellomo, John A. Kellum, Claudio Ronco · Intensive Care Medicine	31 Oct 2001	461
47	Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients Alessandra Carobbio, Jüergen Thiele, Francesco Passamonti et al. · Blood Open access	13 Apr 2011	455
48	Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia Alessandro Maria Vannucchi et al. · Blood	23 Mar 2007	449
49	Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH) Alberto Tosetto, Alfonso Iorio, Maura Marcucci et al. · Journal of Thrombosis and Haemostasis Open access	10 Apr 2012	445
50	Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. Giampietro Gasparini, Adrian L. Harris · Journal of Clinical Oncology	Mar 1995	440

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.